Reduction of adhesion formation by postoperative administration of ionically cross-linked hyaluronic acid

Fertil Steril. 1997 Jul;68(1):37-42. doi: 10.1016/s0015-0282(97)81472-0.

Abstract

Objective: To examine the efficacy of various formulations of hyaluronic acid (HA), including HA ionically cross-linked with trivalent iron, in animal models of adhesion formation.

Design: Hyaluronic acid formulation of varying concentrations and cross-linked densities were prepared and evaluated in a rabbit uterine horn model and a rabbit sidewall model.

Setting: ETHICON, Inc., Somerville, New Jersey.

Subject(s): New Zealand White rabbits.

Intervention(s): Test formulations were applied as intraperitoneal instillates after surgery.

Main outcome measure(s): Adhesion formation was assessed at 7 and 14 days (sidewall and uterine horn model, respectively).

Result(s): Hyaluronic acid that was not ionically cross-linked was ineffective in reducing adhesions in these models even at high viscosity, whereas the ionically cross-linked formulations of HA with trivalent iron were highly effective. Efficacy improved with increased levels of ionic cross-linking. Flowable gels, which could be delivered readily by syringe and cannula, also were effective when administered at a site remote from injury and with saline present.

Conclusion(s): Whereas previous studies show that HA was effective in reducing adhesions peripheral to the site of injury, HA ionically cross-linked with trivalent iron was effective in reducing adhesions at all sites. From these studies, a formulation of HA ionically cross-linked with trivalent iron, 0.5% Ferric Hyaluronate Gel (LUBRICOAT; ETHICON, Inc., Somerville, NJ), was identified for subsequent clinical evaluations.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Female
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / chemistry
  • Hyaluronic Acid / pharmacology*
  • Infusions, Parenteral
  • Iron / chemistry*
  • Peritoneal Diseases / etiology
  • Peritoneal Diseases / prevention & control*
  • Peritoneum / drug effects*
  • Peritoneum / surgery
  • Postoperative Period
  • Rabbits
  • Tissue Adhesions / etiology
  • Tissue Adhesions / prevention & control
  • Uterus / drug effects*
  • Uterus / surgery
  • Viscosity
  • Wound Healing / drug effects
  • Wound Healing / physiology*

Substances

  • Hyaluronic Acid
  • Iron